Cited by 777Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases

Owens, D M, Keyse, S M·2007·Oncogene

Abstract

The regulated dephosphorylation of mitogen-activated protein kinases (MAPKs) plays a key role in determining the magnitude and duration of kinase activation and hence the physiological outcome of signalling. In mammalian cells, an important component of this control is mediated by the differential expression and activities of a family of 10 dual-specificity (Thr/Tyr) MAPK phosphatases (MKPs). These enzymes share a common structure in which MAPK substrate recognition is determined by sequences within an amino-terminal non-catalytic domain whereas MAPK binding often leads to a conformational change within the C-terminal catalytic domain resulting in increased enzyme activity. MKPs can either recognize and inactivate a single class of MAP kinase, as in the specific inactivation of extracellular signal regulated kinase (ERK) by the cytoplasmic phosphatase DUSP6/MKP-3 or can regulate more than one MAPK pathway as illustrated by the ability of DUSP1/MKP-1 to dephosphorylate ERK, c-Jun amino-terminal kinase and p38 in the cell nucleus. These properties, coupled with transcriptional regulation of MKP expression in response to stimuli that activate MAPK signalling, suggest a complex negative regulatory network in which individual MAPK activities can be subject to negative feedback control, but also raise the possibility that signalling through multiple MAPK pathways may be integrated at the level of regulation by MKPs.

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1210412

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DUSPs/MKPs have two structured domains: an N-terminal MAPK binding domain (MKBD) and a C-terminal dual specificity phosphatase domain.

    “However, unlike the KIM-PTPs, the DUSPs/MKPs have two structured domains: an N-terminal MAPK binding domain (MKBD) and a C-terminal dual specificity phosphatase domain [Fig.1(B), right].”

    From Molecular basis of MAP kinase regulation (2013) · cites this paper as [11]

  • The domain architecture of typical DUSPs/MKPs is highly similar, with a modestly conserved N-terminal MKBD domain and a more highly conserved C-terminal catalytic domain.

    “The domain architecture of typical DUSPs/ MKPs is highly similar with a modestly conserved N-terminal MKBD domain and the more highly conserved C-terminal catalytic domain”

    From Molecular basis of MAP kinase regulation (2013) · cites this paper as [11]

  • Ten DUSPs contain a MAPK binding domain (MKBD) with a KIM interaction sequence that is required for a direct interaction with MAPKs.

    “Ten DUSPs contain a MAPK binding domain (MKBD) with a KIM interaction sequence that is required for a direct interaction with MAPKs.”

    From Molecular basis of MAP kinase regulation (2013) · cites this paper as [11]

  • The DUSP active site is shallow, more similar to the depth of the active sites of serine/threonine specific phosphatases than to that of tyrosine phosphatases.

    “the DUSP active site is shallow 11,34 -more similar to the depth of the active sites of serine/ threonine specific phosphatases [79][80][81] -when directly compared with that of tyrosine phosphatases, 38”

    From Molecular basis of MAP kinase regulation (2013) · cites this paper as [11]

The citation lists haven’t been fetched yet

References 74 · Cited by 777

Authors
Owens, D. M., & Keyse, S. M.
Affiliations
University of Dundee (GB)
Corresponding author
Keyse, S M
Venue
Oncogene
Published
2007-05-14
Volume
26
Issue
22
Pages
3203-3213
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2128251228
Cited by
777
References
74
Citations by year
2026: 14 · 2025: 24 · 2024: 20 · 2023: 25 · 2022: 31 · 2021: 34 · 2020: 34 · 2019: 27 · 2018: 44 · 2017: 44 · 2016: 35 · 2015: 39 · 2014: 43 · 2013: 56 · 2012: 59
FWCI
4.53
Type
journal article
Language
en
Open access
closed
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
MAPK signaling, dual-specificity phosphatase, MKP-1, MKP-3, ERK dephosphorylation, c-Jun N-terminal kinase, p38 MAPK, negative feedback regulation, substrate recognition
MeSH terms
Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Phosphoprotein Phosphatases, Phosphorylation, Protein Tyrosine Phosphatases, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review